Primary cutaneous angiomatoid melanoma

Primary cutaneous angiomatoid melanoma Correspondence Clinical Letter erythrocytes. These channels were lined by neoplastic cells Clinical Letter that were negative for endothelial markers D2-40 and CD- 31. Further immunohistochemical staining showed consis- tent positivity for melanocytic markers (S-100, SOX-9, and HMB-45) and negativity for cytokeratins A1–A3 (Figure 2). Given the clinical and histological findings, a diagnosis DOI: 10.1111/ddg.13437 of primary angiomatoid melanoma (Clark level III, Bres- low thickness 5.2 mm, with evidence of ulceration between Dear Editors, 3–5 mm) was established. Whole-body positron emission to- mography-computed tomography (PET-CT) was performed, A 63-year-old woman with no relevant medical history revealing metastatic disease in the lungs, liver, and celiac presented to our hospital with changes in the morphology lymph nodes. Genetic testing for both V600E and V600K and color of a chronic cutaneous lesion. Two weeks prior mutations of the BRAF gene was performed using real-time to consultation, the lesion had bled profusely, subsequently PCR (THxID-BRAF AMP, bioMérieux, France), revealing decreasing significantly in size. Dermatological examination a V600E mutation. Following the diagnosis, the patient was revealed a purplish tumor (1.5 cm in diameter) in the right referred to the oncology department and started on vemura- scapular region, arising from a slightly raised brown papule. fenib http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal Der Deutschen Dermatologischen Gesellschaft Wiley

Loading next page...
 
/lp/wiley/primary-cutaneous-angiomatoid-melanoma-jmsyWFSUM2
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.
ISSN
1610-0379
eISSN
1610-0387
D.O.I.
10.1111/ddg.13437
Publisher site
See Article on Publisher Site

Abstract

Correspondence Clinical Letter erythrocytes. These channels were lined by neoplastic cells Clinical Letter that were negative for endothelial markers D2-40 and CD- 31. Further immunohistochemical staining showed consis- tent positivity for melanocytic markers (S-100, SOX-9, and HMB-45) and negativity for cytokeratins A1–A3 (Figure 2). Given the clinical and histological findings, a diagnosis DOI: 10.1111/ddg.13437 of primary angiomatoid melanoma (Clark level III, Bres- low thickness 5.2 mm, with evidence of ulceration between Dear Editors, 3–5 mm) was established. Whole-body positron emission to- mography-computed tomography (PET-CT) was performed, A 63-year-old woman with no relevant medical history revealing metastatic disease in the lungs, liver, and celiac presented to our hospital with changes in the morphology lymph nodes. Genetic testing for both V600E and V600K and color of a chronic cutaneous lesion. Two weeks prior mutations of the BRAF gene was performed using real-time to consultation, the lesion had bled profusely, subsequently PCR (THxID-BRAF AMP, bioMérieux, France), revealing decreasing significantly in size. Dermatological examination a V600E mutation. Following the diagnosis, the patient was revealed a purplish tumor (1.5 cm in diameter) in the right referred to the oncology department and started on vemura- scapular region, arising from a slightly raised brown papule. fenib

Journal

Journal Der Deutschen Dermatologischen GesellschaftWiley

Published: Jan 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off